|
1
|
Shah MA and Ajani JA: Gastric cancer-an
enigmatic and heterogeneous disease. JAMA. 303:1753–1754. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Van Cutsem E, Sagaert X, Topal B,
Haustermans K and Prenen H: Gastric cancer. Lancet. 388:2654–2664.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Suzuki H, Iwasaki E and Hibi T:
Helicobacter pylori and gastric cancer. Gastric Cancer. 12:79–87.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kato S, Tsukamoto T, Mizoshita T, Tanaka
H, Kumagai T, Ota H, Katsuyama T, Asaka M and Tatematsu M: High
salt diets dose-dependently promote gastric chemical carcinogenesis
in Helicobacter pylori-infected Mongolian gerbils associated with a
shift in mucin production from glandular to surface mucous cells.
Int J Cancer. 119:1558–1566. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Milne AN, Carneiro F, O'Morain C and
Offerhaus GJ: Nature meets nurture: Molecular genetics of gastric
cancer. Hum Genet. 126:615–628. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gomceli I, Demiriz B and Tez M: Gastric
carcinogenesis. World J Gastroenterol. 18:5164–5170.
2012.PubMed/NCBI
|
|
8
|
Hartgrink HH, Jansen EP, van Grieken NC
and van de Velde CJ: Gastric cancer. Lancet. 374:477–490. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wagner AD and Moehler M: Development of
targeted therapies in advanced gastric cancer: Promising
exploratory steps in a new era. Curr Opin Oncol. 21:381–385. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cao Y, Liu X, Lu W, Chen Y, Wu X, Li M,
Wang XA, Zhang F, Jiang L, Zhang Y, et al: Fibronectin promotes
cell proliferation and invasion through mTOR signaling pathway
activation in gallbladder cancer. Cancer Lett. 360:141–150. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fernandez-Garcia B, Eiró N, Marín L,
González-Reyes S, González LO, Lamelas ML and Vizoso FJ: Expression
and prognostic significance of fibronectin and matrix
metalloproteases in breast cancer metastasis. Histopathology.
64:512–522. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
von Au A, Vasel M, Kraft S, Sens C, Hackl
N, Marx A, Stroebel P, Hennenlotter J, Todenhöfer T, Stenzl A, et
al: Circulating fibronectin controls tumor growth. Neoplasia.
15:925–938. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gao M, Craig D, Lequin O, Campbell ID,
Vogel V and Schulten K: Structure and functional significance of
mechanically unfolded fibronectin type III1 intermediates. Proc
Natl Acad Sci USA. 100:14784–14789. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Anderegg U, Breitschwerdt K, Köhler MJ,
Sticherling M, Haustein UF, Simon JC and Saalbach A: MEL4B3, a
novel mRNA is induced in skin tumors and regulated by TGF-beta and
pro-inflammatory cytokines. Exp Dermatol. 14:709–718. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bell A, Bell D, Weber RS and El-Naggar AK:
CpG island methylation profiling in human salivary gland adenoid
cystic carcinoma. Cancer. 117:2898–2909. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Das DK, Naidoo M, Ilboudo A, Park JY, Ali
T, Krampis K, Robinson BD, Osborne JR and Ogunwobi OO: miR-1207-3p
regulates the androgen receptor in prostate cancer via
FNDC1/fibronectin. Exp Cell Res. 348:190–200. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
van Ingen G, Li J, Goedegebure A, Pandey
R, Li YR, March ME, Jaddoe VW, Bakay M, Mentch FD, Thomas K, et al:
Genome-wide association study for acute otitis media in children
identifies FNDC1 as disease contributing gene. Nat Commun.
7:127922016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sato M, Cismowski MJ, Toyota E, Smrcka AV,
Lucchesi PA, Chilian WM and Lanier SM: Identification of a
receptor-independent activator of G protein signaling (AGS8) in
ischemic heart and its interaction with Gbetagamma. Proc Natl Acad
Sci USA. 103:797–802. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sato M, Jiao Q, Honda T, Kurotani R,
Toyota E, Okumura S, Takeya T, Minamisawa S, Lanier SM and Ishikawa
Y: Activator of G protein signaling 8 (AGS8) is required for
hypoxia-induced apoptosis of cardiomyocytes: Role of G betagamma
and connexin 43 (CX43). J Biol Chem. 284:31431–31440. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu CT, Garnaas MK, Tin A, Kottgen A,
Franceschini N, Peralta CA, de Boer IH, Lu X, Atkinson E, Ding J,
et al: Genetic association for renal traits among participants of
African ancestry reveals new loci for renal function. PLoS Genet.
7:e10022642011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hayashi H, Al Mamun A, Sakima M and Sato
M: Activator of G-protein signaling 8 is involved in VEGF-mediated
signal processing during angiogenesis. J Cell Sci. 129:1210–1222.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bosman FT, Carneiro F, Hruban RH and
Theise ND: WHO classification of tumours of the digestive system.
4th. International Agency for Research on Cancer; Lyon: 2010
|
|
23
|
Amin MB, Edge S, Greene FL, Schilsky RL,
Gaspar LE, Washington MK, Sullivan DC, Brookland RK, Brierley JD,
Balch CM, et al: AJCC cancer staging manual. 8th ed. Springer; New
York: 2017, View Article : Google Scholar
|
|
24
|
Cho JY, Lim JY, Cheong JH, Park YY, Yoon
SL, Kim SM, Kim SB, Kim H, Hong SW, Park YN, et al: Gene expression
signature-based prognostic risk score in gastric cancer. Clin
Cancer Res. 17:1850–1857. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
D'Errico M, de Rinaldis E, Blasi MF, Viti
V, Falchetti M, Calcagnile A, Sera F, Saieva C, Ottini L, Palli D,
et al: Genome-wide expression profile of sporadic gastric cancers
with microsatellite instability. Eur J Cancer. 45:461–469. 2009.
View Article : Google Scholar
|
|
26
|
Wang Q, Wen YG, Li DP, Xia J, Zhou CZ, Yan
DW, Tang HM and Peng ZH: Upregulated INHBA expression is associated
with poor survival in gastric cancer. Med Oncol. 29:77–83. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45(W1):
W98–W102. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wan J, Liu H, Feng Q, Liu J and Ming L:
HOXB9 promotes endometrial cancer progression by targeting E2F3.
Cell Death Dis. 9:5092018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang Y, Fu D, Chen Y, Su J, Wang Y, Li X,
Zhai W, Niu Y, Yue D and Geng H: G3BP1 promotes tumor progression
and metastasis through IL-6/G3BP1/STAT3 signaling axis in renal
cell carcinomas. Cell Death Dis. 9:5012018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang Z, Yang F, Zhang Y, Wang X, Shi J,
Wei H, Sun F and Yu Y: Girdin protein: A potential metastasis
predictor associated with prognosis in lung cancer. Exp Ther Med.
15:2837–2843. 2018.PubMed/NCBI
|
|
31
|
Liu Y, Yao X, Zhang Q, Qian L, Feng J,
Bian T, Zhang J and Tian Y: Expression of Kruppel-like factor 8 and
Ki67 in lung adenocarcinoma and prognosis. Exp Ther Med.
14:1351–1356. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li D, Ding J, Wang X, Wang C and Wu T:
Fibronectin promotes tyrosine phosphorylation of paxillin and cell
invasiveness in the gastric cancer cell line AGS. Tumori.
95:769–779. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tas F, Bilgin E, Karabulut S, Tastekin D
and Duranyildiz D: Levels of serum fibronectin as a biomarker in
gastric cancer patients: Correlation with clinical diagnosis and
outcome. Mol Clin Oncol. 4:655–659. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
O'Byrne KJ and Dalgleish AG: Chronic
immune activation and inflammation as the cause of malignancy. Br J
Cancer. 85:473–483. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Aggarwal BB, Shishodia S, Sandur SK,
Pandey MK and Sethi G: Inflammation and cancer: How hot is the
link? Biochem Pharmacol. 72:1605–1621. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Poon RT, Fan ST and Wong J: Clinical
implications of circulating angiogenic factors in cancer patients.
J Clin Oncol. 19:1207–1225. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tischer E, Gospodarowicz D, Mitchell R,
Silva M, Schilling J, Lau K, Crisp T, Fiddes JC and Abraham JA:
Vascular endothelial growth factor: A new member of the
platelet-derived growth factor gene family. Biochem Biophys Res
Commun. 165:1198–1206. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kowanetz M and Ferrara N: Vascular
endothelial growth factor signaling pathways: Therapeutic
perspective. Clin Cancer Res. 12:5018–5022. 2006. View Article : Google Scholar : PubMed/NCBI
|
